Nivolumab Achieves High ORR and Durable PFS in Patients with dMMR/MSI-H Recurrent Endometrial or Ovarian Cancer
Genomic and tumour microenvironment parameters associated with response to PD1 blockade in dMMR cancers
Patient Guide on Bone Health in Cancer Now Available in Spanish
Expanding the guide’s availability in more languages
Medical Oncologists Incredulous at the Commission’s Latest Backtracking on the Evaluation of the EU Tobacco Products Directive
Following the Ombudsman’s recent findings of maladministration regarding the Commission’s interactions with tobacco lobbyists and its subsequent decision not to bring forward the proposed Council recommendation on smoke-free environments, it is beyond belief that the Commission now appears to have removed plans to publish an evaluation – originally meant to come in 2022 - of the Tobacco Products Directive from its implementation
FDA Grants Accelerated Approval to Tovorafenib for Patients with Relapsed or Refractory BRAF-Altered Paediatric Low-Grade Glioma
Evidence for efficacy is based on the results from the FIREFLY-1 study
Tanja Gagliardi
ESMO Guidelines: Real World Cases - Webinar Series: Venous Thromboembolism in Cancer Patients 2024
Virtual Meeting